GlassScriptPhysician profile
William T Dawson
NPI 1821291915
$11,280.24
in general payments reported to CMS, 2019-2025
49 companies · $1,963 in 2025
The $1,963 reported for 2025 was more than what 90% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $94.92 · 2021: $156 · 2022: $853 · 2023: $6,295 · 2024: $1,099 · 2025: $1,963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,606 · Honoraria: $3,000 · Travel and Lodging: $1,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,605.66 |
| Honoraria | $3,000.00 |
| Travel and Lodging | $1,750.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $7,121.29 | 2022-2025 | Trinav Infusion System |
| Sirtex Medical INC | $570.87 | 2019-2022 | |
| Boston Scientific Corporation | $568.02 | 2019-2025 | Embold Fibered, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Cook Medical LLC | $366.52 | 2019-2022 | |
| Penumbra, INC. | $266.41 | 2024-2025 | Indigo System, Ruby Coil |
| Merck Sharp & Dohme LLC | $210.33 | 2021-2023 | Keytruda, Reblozyl, Lynparza |
| W. L. Gore & Associates, INC. | $150.62 | 2023 | Viatorr Tips Endoprosthesis W/ Controlled Expansion |
| Janssen Biotech, INC. | $135.61 | 2020-2025 | Tecvayli, Darzalex, Akeega |
| Genzyme Corporation | $132.94 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $130.62 | 2019-2023 | Tazverik, Onivyde, Somatuline Depot |
| Eisai INC. | $117.44 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $114.17 | 2019-2025 | Imfinzi, Lynparza, Enhertu |
| Cardiva Medical, INC. | $109.11 | 2023 | Cardiva Vascade 6/7f Vcs |
| Daiichi Sankyo INC. | $107.43 | 2020-2025 | Injectafer, Enhertu |
| Stryker Corporation | $107.09 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.